Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS

by NASDAQ Market News December 28, 2021

NASDAQ Market News
Click here to email author

At 9% CAGR, Global Targeted Therapy Market to Surpass US$ 180.3 Billion by 2028, Says Coherent Market Insights (CMI)

The Global In-vitro Diagnostics Market is expected to grow by $ 35.77 bn during 2021-2025, progressing at a CAGR of 7.95% during the forecast period

Ads